AdaptHealth (AHCO) Liabilities and Shareholders Equity (2017 - 2026)
AdaptHealth (AHCO) posted quarterly Liabilities and Shareholders Equity of $4.4 billion for Q1 2026, little changed year-over-year from $4.4 billion in Q1 2025, and up 2.49% quarter-over-quarter from $4.3 billion in Q4 2025.
AdaptHealth (AHCO) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
AdaptHealth's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $4.4 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed 0.3% year-over-year to $4.4 billion; the TTM figure through Mar 2026 stood at $17.5 billion (down 2.4% YoY), while the FY2025 annual figure was $4.3 billion, down 3.8% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $4.4 billion, up from $4.3 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $5.3 billion in Q1 2023, with the low at $4.3 billion in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $4.5 billion (2023), against an average of $4.7 billion.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity increased 15.14% in 2022, then fell 14.76% in 2024.
- AdaptHealth's Liabilities and Shareholders Equity stood at $5.2 billion in 2022, then slipped by 13.62% to $4.5 billion in 2023, then retreated by 0.48% to $4.5 billion in 2024, then slipped by 3.8% to $4.3 billion in 2025, then gained by 2.49% to $4.4 billion in 2026.
- Business Quant data shows AHCO's Liabilities and Shareholders Equity at $4.4 billion in Q1 2026, $4.3 billion in Q4 2025, and $4.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | AdaptHealth | 730.28 Mn | 686.99 Mn | 104.21 Mn | 4.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.34 Bn |
| Mar 31, 2026 | 4.42 Bn |
| Dec 31, 2025 | 4.32 Bn |
| Sep 30, 2025 | 4.38 Bn |
| Jun 30, 2025 | 4.35 Bn |
| Mar 31, 2025 | 4.44 Bn |
| Dec 31, 2024 | 4.49 Bn |
| Sep 30, 2024 | 4.47 Bn |
| Jun 30, 2024 | 4.51 Bn |
| Mar 31, 2024 | 4.50 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Sep 30, 2023 | 4.73 Bn |
| Jun 30, 2023 | 5.20 Bn |
| Mar 31, 2023 | 5.28 Bn |
| Dec 31, 2022 | 5.22 Bn |
| Sep 30, 2022 | 5.24 Bn |
| Jun 30, 2022 | 5.20 Bn |
| Mar 31, 2022 | 5.20 Bn |
| Dec 31, 2021 | 5.25 Bn |
| Sep 30, 2021 | 5.19 Bn |